It has been shown in other cancer cells that RAD51 expression can be transcriptionally regulated by various signaling pathways, including regulation by the MAPK signaling pathway and downstream effectors such as cMyc or EGR and Elk120–23. This evidence concerns the gene MYC and cancer.